Castle Biosciences Inc
NASDAQ:CSTL
Castle Biosciences Inc
Net Income (Common)
Castle Biosciences Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Castle Biosciences Inc
NASDAQ:CSTL
|
Net Income (Common)
-$30.8m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Net Income (Common)
$815.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
44%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Income (Common)
$842m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
3%
|
CAGR 10-Years
0%
|
|
CVS Health Corp
NYSE:CVS
|
Net Income (Common)
$7.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
Cigna Corp
NYSE:CI
|
Net Income (Common)
$3.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Income (Common)
$433.1m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
See Also
What is Castle Biosciences Inc's Net Income (Common)?
Net Income (Common)
-30.8m
USD
Based on the financial report for Mar 31, 2024, Castle Biosciences Inc's Net Income (Common) amounts to -30.8m USD.
What is Castle Biosciences Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-31%
Over the last year, the Net Income (Common) growth was 57%. The average annual Net Income (Common) growth rates for Castle Biosciences Inc have been -27% over the past three years , -31% over the past five years .